MacroGenics Revenue Per Share from 2010 to 2024

MGNX Stock  USD 3.29  0.05  1.54%   
MacroGenics Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 0.90 in 2024. Revenue Per Share is the amount of revenue generated by MacroGenics per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
0.94864784
Current Value
0.9
Quarterly Volatility
1.93896844
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.5 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 4.1. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of MacroGenics over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. MacroGenics' Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.26410 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

MacroGenics Revenue Per Share Regression Statistics

Arithmetic Mean2.61
Geometric Mean2.16
Coefficient Of Variation74.41
Mean Deviation1.21
Median2.47
Standard Deviation1.94
Sample Variance3.76
Range7.7978
R-Value(0.49)
Mean Square Error3.06
R-Squared0.24
Significance0.06
Slope(0.21)
Total Sum of Squares52.63

MacroGenics Revenue Per Share History

2024 0.9
2023 0.95
2022 2.47
2021 1.26
2020 1.86
2019 1.29
2018 1.47

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 0.95  0.90 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.